Future Rheumatology

Psoriasis occurring during anti-TNF-α therapy: causal effect or unrelated?
pp. 281-284(4)
Authors: Stratigos, Alexander J; Sfikakis, Petros P

Estrogen levels and hip fracture in men
pp. 285-287(3)

Current status and future prospects in the management of bone disease
pp. 289-291(3)
Author: McCloskey, Eugene

Rituximab: B-cell depletion therapy for the treatment of rheumatoid arthritis
pp. 293-302(10)
Authors: Dass, Shouvik; Vital, Edward M; Emery, Paul

Febuxostat: a safe and effective therapy for hyperuricemia and gout
pp. 303-309(7)
Authors: Jordan, Natasha; McCarthy, Geraldine M

A genomic view of subtypes in rheumatoid arthritis: towards personalized medicine
pp. 311-322(12)
Authors: van Baarsen, Lisa GM; van der Pouw-Kraan, Tineke CTM; Verweij, Cornelis L

Arachidonic acid-derived eicosanoids in rheumatoid arthritis: implications and future targets
pp. 323-330(8)
Authors: Kapoor, Mohit; Kojima, Fumiaki; Crofford, Leslie J

Treatments for psoriatic arthritis
pp. 331-338(8)
Author: McHugh, Neil John

Peptide vaccines against arthritis
pp. 339-344(6)
Author: Root-Bernstein, Robert

Antiphospholipid syndrome: treatment controversies
pp. 345-353(9)
Authors: Ruiz-Irastorza, Guillermo; Khamashta, Munther A

Thrombotic microangiopathic antiphospholipid syndromes: a continuum of conditions?
pp. 355-364(10)
Authors: Asherson, Ronald A; Cervera, Ricard; Merrill, Joan T

Antinuclear antibodies in systemic sclerosis
pp. 365-371(7)
Authors: Codullo, Veronica; Bardoni, Anna; Salvini, Roberta; Montecucco, Carlomaurizio

Paget's disease of the hip: surgical management
pp. 373-377(5)
Authors: Parvizi, Javad; Restrepo, Camilo; Sim, Franklin H